FDA Expands Use of Herceptin for Early Stage Breast Cancer
FDA Expands Use of Herceptin for Early Stage Breast Cancer After Primary Therapy
The new indication is for Herceptin, in combination with other cancer drugs, for the treatment of HER2 positive breast cancer after surgery (lumpectomy or mastectomy).